MASS_OUT_1 [2025-04-14 14:16:04 -0400] 3109 Bytes | 813 tokens | Cum: 813 tkns (10.16% of 8k)
==========================================================================

We need a winner today and it's already 2:16:03 PM on Mon Apr 14, 2025 -0400 ... So let's find out if 908 Devices (MASS) is going up or if it's going nowhere fast. So, I pulled together a bunch of data for you to look over real fast. It's at 4.2400 up from 4.2100. Is there something here we can get excited about? Help me analyze.

--- COMPANY PROFILE ---
Company: 908 Devices (MASS)
IPO: 2020-12-18 (4 Years Ago)
Market Cap: $145,912,871
Shares Outstanding: 35,330,000
Industry: MEASURING & CONTROLLING DEVICES, NEC
Exchange: XNAS
Description: 908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.

Here’s the first list of news for 908 Devices:

C1 - Mar-11-25 07:00AM - 908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device
C2 - Mar-05-25 05:14AM - Q4 2024 908 Devices Inc. Earnings Call
C3 - Mar-05-25 05:14AM 02:05AM - 908 Devices Inc (MASS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ...
C4 - Mar-04-25 01:26PM - 908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth
C5 - Mar-04-25 01:26PM 09:30AM - 908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates
C6 - Mar-04-25 01:26PM 07:45AM - 908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results
C7 - Mar-04-25 01:26PM 07:30AM - Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices
C8 - Mar-03-25 05:00PM - 908 Devices to Participate in Upcoming Investor Conferences

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**. I am **ScanScor**, a unified document retrieval and report parser.
Your role is to examine all available company data and draw sound conclusions.
The company under analysis is: 908 Devices (MASS).

2) To request information, refer to any listed documents using their reference codes.

3) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs:

Restrict all your responses to just 3 tokes until it's time for the summary and data pairs at the end.
Request a document with its reference code(s), such as:
- `C1`, `C2`, `C3`, etc.
- To load more documents, reply with: `NEX`

News articles, SEC filings, and key metrics will be revealed in subsequent prompts.
Stay focused. Gather evidence. Continue until your conclusions are clear.

MASS_OUT_3 [2025-04-14 14:16:05 -0400] 251 Bytes | 78 tokens | Cum: 894 tkns (11.18% of 8k)
==========================================================================

You just read a chunk of A1.
You may now:
- Say "MOR" to continue this article
- Say "A2", "A3", etc. to request another
- Or say "NEX" to move to the next source

You are allowed up to 3 articles from this list. If you’re ready to move on, say NEX.

MASS_OUT_5 [2025-04-14 14:16:05 -0400] 861 Bytes | 269 tokens | Cum: 1166 tkns (14.57% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-10T06:07:48Z - 908 Devices (NASDAQ:MASS) Earns Sell (D-) Rating from Weiss Ratings...
A2 - 2025-04-08T11:07:00Z - The Zacks Analyst Blog Highlights Fidelity NASDAQ Composite Index ETF, ThredUp, 908 Devices, Logilit...
A3 - 2025-04-07T13:01:00Z - 5 Top-Ranked Stocks of Nasdaq ETF Beating the Bear Market...
A4 - 2025-04-03T16:58:55Z - 908 Devices Inc. (NASDAQ:MASS) Short Interest Up 26.7% in March...
A5 - 2025-04-01T11:57:00Z - New Strong Buy Stocks for April 1st...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

MASS_OUT_7 [2025-04-14 14:16:06 -0400] 1098 Bytes | 322 tokens | Cum: 1490 tkns (18.62% of 8k)
==========================================================================

Showing A1 (chunk 1 of 4): A1:
**908 Devices (NASDAQ:MASS) Earns Sell (D-) Rating from Weiss Ratings**Date: 2025-04-10Source: {'uri': 'marketbeat.com', 'dataType': 'news', 'title': 'Market Beat'}URL: https://www.marketbeat.com/instant-alerts/908-devices-nasdaqmass-earns-sell-d-rating-from-weiss-ratings-2025-04-09/Separately, Stephens reissued an "overweight" rating and issued a $6.00 price objective on shares of 908 Devices in a report on Wednesday, January 15th. Two analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, 908 Devices currently has an average rating of "Moderate Buy" and a consensus target price of $5.33.

Check Out Our Latest Stock Report on 908 Devices

MASS opened at $3.63 on Tuesday. The stock has a market capitalization of $128.25 million, a price-to-earnings ratio of -2.05 and a beta of 0.30. The firm has a 50 da

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

MASS_OUT_9 [2025-04-14 14:16:08 -0400] 1098 Bytes | 292 tokens | Cum: 1784 tkns (22.30% of 8k)
==========================================================================

Showing A1 (chunk 2 of 4): y moving average price of $3.25 and a 200-day moving average price of $2.96. 908 Devices has a twelve month low of $1.81 and a twelve month high of $7.48.

Large investors have recently modified their holdings of the stock. Two Sigma Advisers LP bought a new stake in shares of 908 Devices during the fourth quarter worth $30,000. Prudential Financial Inc. purchased a new position in 908 Devices in the 4th quarter worth about $34,000. Occudo Quantitative Strategies LP bought a new stake in 908 Devices during the 4th quarter valued at about $36,000. Two Sigma Investments LP purchased a new stake in 908 Devices in the 4th quarter valued at about $42,000. Finally, B. Riley Wealth Advisors Inc. purchased a new stake in 908 Devices in the 3rd quarter valued at about $45,000. Institutional investors own 88.06% of the company's stock.

908 Devices Inc, a commercial-stage technology company, provi

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

MASS_OUT_11 [2025-04-14 14:16:13 -0400] 1098 Bytes | 242 tokens | Cum: 2051 tkns (25.64% of 8k)
==========================================================================

Showing A1 (chunk 3 of 4): des various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.

This instant news alert was generated by narrative science technology

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

MASS_OUT_13 [2025-04-14 14:16:18 -0400] 1002 Bytes | 223 tokens | Cum: 2360 tkns (29.50% of 8k)
==========================================================================

Showing A1 (chunk 4 of 4): and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider 908 Devices, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and 908 Devices wasn't on the list.

While 908 Devices currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

MASS_OUT_15 [2025-04-14 14:16:18 -0400] 976 Bytes | 326 tokens | Cum: 2795 tkns (34.94% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-05-14T13:55:13Z - Wall Street Analysts Predict a 133.69% Upside in 908 Devices (MASS): Here's What You Should Know
B2 - 2024-05-09T13:35:05Z - 908 Devices (MASS) Loses -9.95% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
B3 - 2024-04-30T12:55:03Z - 908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates
B4 - 2024-04-25T14:02:04Z - IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth
B5 - 2024-04-18T21:15:04Z - Intuitive Surgical, Inc. (ISRG) Q1 Earnings and Revenues Top Estimates
B6 - 2024-03-08T06:40:09Z - Cathie Wood Sells $13.15M Worth Of Coinbase Shares Amid Bitcoin Flirting With All-Time High Levels — Shops For Palantir Stock Instead

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

MASS_OUT_17 [2025-04-14 14:16:26 -0400] 770 Bytes | 213 tokens | Cum: 3010 tkns (37.62% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**Wall Street Analysts Predict a 133.69% Upside in 908 Devices (MASS): Here's What You Should Know**Date: Unknown DateSource: Unknown SourceURL: https://www.zacks.com/stock/news/2273548/wall-street-analysts-predict-a-13369-upside-in-908-devices-mass-heres-what-you-should-knowThe average of price targets set by Wall Street analysts indicates a potential upside of 133.7% in 908 Devices (MASS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

MASS_OUT_19 [2025-04-14 14:16:26 -0400] 1098 Bytes | 282 tokens | Cum: 3494 tkns (43.68% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S2 - 2025-03-07 10-K Item 7. Mgts Discussion and Analysis of Fin Cond and Results of Oper.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our CONS financial statements and related notes ap...

S7 - 2025-03-04 8-K ITEM 1.01 . Entry into a Material Definitive Agrmt.

On March 4, 2025, 908 Devices Inc. (the Company ) completed the sale of all issued and outstanding equity interests of its wholly-owned subsidiary, 908 Devices GmbH (the Transferred Company and such equity interests, the T...

S8 - 2025-03-04 8-K Item 2.02 Results of Oper and Fin Cond.

On March 4, 2025, 908 Devices Inc. ( 908 Devices ) announced its financial results for the fourth quarter and fiscal year ended December 31, 2024. A copy of the press release is being furnished as Exhibit 99.1 to this Rep...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

MASS_OUT_21 [2025-04-14 14:16:28 -0400] 1098 Bytes | 234 tokens | Cum: 3730 tkns (46.62% of 8k)
==========================================================================

Showing S2 (chunk 1 of 6): S2:
Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and related notes appearing in Part II, Item 8 of this Annual Report on Form 10-K. Some of the information contained in this discussion and analysis or set forth elsewhere in this Annual Report on Form 10-K, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in the Risk Factors section of this Annual Report on Form 10-K, our actual results could differ materially from the results described in, or implied by, the forward-looking statements contained in the following di

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

MASS_OUT_23 [2025-04-14 14:16:29 -0400] 1098 Bytes | 229 tokens | Cum: 4013 tkns (50.16% of 8k)
==========================================================================

Showing S2 (chunk 2 of 6): scussion and analysis.

Overview

We have developed an innovative suite of purpose-built handheld and desktop devices for point-of-need chemical analysis. Leveraging complementary analytical technologies including our proprietary mass spectrometry, or Mass Spec, microfluidics, and analytics and machine learning technologies, we make devices that are significantly smaller and more accessible than conventional laboratory instruments. Our devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets.

We create simplified measurement devices that our customers can use as accurate tools where and when their work needs to be done, rather than overly complex and centralized analytical instr

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

MASS_OUT_25 [2025-04-14 14:16:34 -0400] 9941 Bytes | 2577 tokens | Cum: 6592 tkns (82.40% of 8k)
==========================================================================

This is our set of metrics for 908 Devices.
Please analyze the numbers.

+-------------------+-----------------------+-------------------------+------------------------+
| Volume: 323,595 | Perf Month: 2.80% | Option/Short: Yes / Yes | Sales Y/Y TTM: 18.72% |
+-------------------+-----------------------+-------------------------+------------------------+
| Avg Volume: 3.10M | Perf Quarter: 110.20% | Short Float: 9.95% | ROE: -51.56% |
+-------------------+-----------------------+-------------------------+------------------------+
| Rel Volume: 0.15 | Index: RUT | Short Ratio: 0.83 | ROI: -60.51% |
+-------------------+-----------------------+-------------------------+------------------------+
| RSI (14): 56.83 | Market Cap: 149.27M | Short Interest: 2.56M | Sales Surprise: 12.65% |
+-------------------+-----------------------+-------------------------+------------------------+
| ATR (14): 0.44 | Shs Outstand: 35.10M | Beta: 0.31 | EPS Surprise: -62.51% |
+-------------------+-----------------------+-------------------------+------------------------+
| SMA20: 4.05% | Shs Float: 25.74M | Sales Q/Q: 31.14% | P/E: - |
+-------------------+-----------------------+-------------------------+------------------------+
| SMA50: 26.24% | Inst Own: 54.11% | Sales past 5Y: 28.70% | Earnings: Mar 04 BMO |
+-------------------+-----------------------+-------------------------+------------------------+
| SMA200: 21.69% | Insider Own: 27.15% | Employees: 246 | |
+-------------------+-----------------------+-------------------------+------------------------+
| Perf Week: 10.89% | Insider Trans: -0.45% | Debt/Eq: 0.06 | |
+-------------------+-----------------------+-------------------------+------------------------+

The next section covers any insider trading by 908 Devices officers or majority shareholders (if available).

No transactions recorded.

Inside Trans: 908 Devices Inc. (MASS) by Knopp Kevin J. (President and CEO) on 2025-03-03
- Stock Option (option to buy): 90518 shares at $0 (D)
- Restricted Stock Units: 198864 shares at $0 (D)

Inside Trans: 908 Devices Inc. (MASS) by Griffith Joseph H. IV (Chief Financial Officer) on 2025-03-03
- Stock Option (option to buy): 59362 shares at $0 (D)
- Restricted Stock Units: 130418 shares at $0 (D)

Inside Trans: 908 Devices Inc. (MASS) by Turner Michael S. (Chief Legal & Admin Officer) on 2025-03-03
- Stock Option (option to buy): 57111 shares at $0 (D)
- Restricted Stock Units: 125470 shares at $0 (D)

Inside Trans: 908 Devices Inc. (MASS) by Hunt Anthony (Unknown Title) on 2025-03-02
- Common Stock: 2058 shares at $N/A (D)
- Restricted Stock Units: 2058 shares at $0 (D)

Inside Trans: 908 Devices Inc. (MASS) by Brown Christopher D. (Chief Product Officer) on 2025-02-01
- Common Stock: 5027 shares at $N/A (D)
- Common Stock: 7418 shares at $N/A (D)
- Common Stock: 10991 shares at $N/A (D)
- Common Stock: 1667 shares at $2.3554 (D) Footnote: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- Common Stock: 2459 shares at $2.3436 (D) Footnote: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- Common Stock: 3641 shares at $2.3349 (D) Footnote: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- Restricted Stock Units: 5027 shares at $0 (D)
- Restricted Stock Units: 7418 shares at $0 (D)
- Restricted Stock Units: 10991 shares at $0 (D)

Inside Trans: 908 Devices Inc. (MASS) by Knopp Kevin J. (President and CEO) on 2025-02-01
- Common Stock: 11254 shares at $N/A (D)
- Common Stock: 13448 shares at $N/A (D)
- Common Stock: 17007 shares at $N/A (D)
- Common Stock: 4318 shares at $2.3307 (D) Footnote: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- Common Stock: 5159 shares at $2.3107 (D) Footnote: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- Common Stock: 6524 shares at $2.3183 (D) Footnote: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- Restricted Stock Units: 11254 shares at $0 (D)
- Restricted Stock Units: 13448 shares at $0 (D)
- Restricted Stock Units: 17007 shares at $0 (D)

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 59631000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -72206000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 4.24
Average Volume: 686070.71
30-Day High: 4.58
30-Day Low: 3.63

[Detailed Financials: TTM 2024]
- Total Assets: $159,476,000.0
- Total Liabilities: $44,884,000.0
- Total Equity: $114,592,000.0
- Current Assets: $103,055,000.0
- Current Liabilities: $25,149,000.0

[Income Statement: TTM 2024]
- Revenue: $59,631,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -2.12

[Cash Flow Statement: TTM 2024]
- Net Cash Flow: $-77,009,000.0

[Detailed Financials: FY 2024]
- Total Assets: $159,476,000.0
- Total Liabilities: $44,884,000.0
- Total Equity: $114,592,000.0
- Current Assets: $103,055,000.0
- Current Liabilities: $25,149,000.0

[Income Statement: FY 2024]
- Revenue: $59,631,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -2.12

[Cash Flow Statement: FY 2024]
- Net Cash Flow: $-77,009,000.0
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of 908 Devices (MASS).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about 908 Devices.

2) MARKET_SCORE[]
This conversation was initiated because MASS is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for MASS.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, MASS could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect MASS to increase 50% from its current price of $4.24, say: PRICE_TARGET[6.36]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of 908 Devices.

11) ETHICAL_RATING[]
Rate 908 Devices’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

Return only: FIELD[value] for each of the above 11 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

MASS_IN_27 [2025-04-14 14:16:35 -0400] 126 Bytes | 29 tokens | Cum: 6784 tkns (84.80% of 8k)
==========================================================================

====================================
[2025-04-14 14:16:35] # Analysis Completed
Elapsed Time: 32.01 seconds